Next Article in Journal
Surgical Treatment in a High-Risk Pulmonary Embolism: Case Report
Previous Article in Journal
Molecular Analysis of Prothrombotic Gene Variants in Patients with Acute Ischemic Stroke and with Transient Ischemic Attack
Case Report

COVID-19 during Early Phase of Autologous Stem Cell Transplantation

1
Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland
2
Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland
3
Department of General and Dental Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland
4
Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University, 71-252 Szczecin, Poland
5
Department of Anaesthesiology and Intensive Care, Pomeranian Medical University, 71-252 Szczecin, Poland
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(7), 724; https://doi.org/10.3390/medicina57070724
Received: 24 June 2021 / Revised: 15 July 2021 / Accepted: 16 July 2021 / Published: 17 July 2021
(This article belongs to the Section Infectious Disease)
We present one of few cases of COVID-19 occurrence during the early phase of autologous hematopoietic stem cell transplantation. We observed an interesting correlation between the patient’s rapid clinical deterioration and myeloid reconstitution that cannot be assigned to engraftment syndrome. Our report emphasizes the need to investigate whether timely steroid therapy upon neutrophil engraftment in the setting of COVID-19 could limit the extent of lung injury and prevent ARDS. Furthermore, we discuss a significant issue of possible prolonged incubation of the virus in heavily pretreated hematological patients. View Full-Text
Keywords: COVID-19; AHSCT; lymphoblastic lymphoma; chemotherapy COVID-19; AHSCT; lymphoblastic lymphoma; chemotherapy
Show Figures

Figure 1

MDPI and ACS Style

Milczarek, S.; Baumert, B.; Sobuś, A.; Wilk-Milczarek, E.; Sommerfeld, K.; Osękowska, B.; Borowiecka, E.; Paczkowska, E.; Łanocha, A.; Poncyliusz, W.; Jarosz, K.; Machaliński, B. COVID-19 during Early Phase of Autologous Stem Cell Transplantation. Medicina 2021, 57, 724. https://doi.org/10.3390/medicina57070724

AMA Style

Milczarek S, Baumert B, Sobuś A, Wilk-Milczarek E, Sommerfeld K, Osękowska B, Borowiecka E, Paczkowska E, Łanocha A, Poncyliusz W, Jarosz K, Machaliński B. COVID-19 during Early Phase of Autologous Stem Cell Transplantation. Medicina. 2021; 57(7):724. https://doi.org/10.3390/medicina57070724

Chicago/Turabian Style

Milczarek, Sławomir, Bartłomiej Baumert, Anna Sobuś, Ewa Wilk-Milczarek, Krzysztof Sommerfeld, Bogumiła Osękowska, Ewa Borowiecka, Edyta Paczkowska, Aleksandra Łanocha, Wojciech Poncyliusz, Konrad Jarosz, and Bogusław Machaliński. 2021. "COVID-19 during Early Phase of Autologous Stem Cell Transplantation" Medicina 57, no. 7: 724. https://doi.org/10.3390/medicina57070724

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop